SEC Form 4 · accession 0000899243-16-023850

CapForce Inc. · CFOR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners

Merck & Co., Inc.

10% Owner

Merck Sharp & Dohme Corp.

10% Owner

Merck Global Health Innovation Fund, LLC

10% Owner

Period of report

Jun 27, 2016

Accepted (ET)

Jun 29, 2016 · 4:05 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001293818

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Jun 27, 2016	A	2,734,427	—	A	5,413,449	I	See Footnote

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Warrants^F1,F2	$1.3125	Jun 27, 2016	P	2,050,821	A	Sep 27, 2016	Jun 27, 2021	Common Stock	2,050,821	2,950,821	I

Explanation of responses

F1The reported securities were included within units ("Units") with each Unit consisting of one share of the Company's common stock, par value $0.01 per share (the "Common Stock") and (ii) a warrant to acquire 0.75 of one share of Common Stock for a purchase price of $1.14375 per Unit.
F2These securities are owned directly by Merck Global Health Innovation Fund, LLC ("MGHIF"), which is a wholly owned subsidiary of Merck Sharp & Dohme Corp. ("MSD"), which is a wholly owned subsidiary of Merck & Co., Inc. ("Merck"). MSD and Merck are indirect beneficial owners of the reported securities.

Remarks

* Ms. Katie Fedosz is signing as Attorney-in-Fact pursuant to power of attorney dated July 23, 2015 granted by each Reporting Person, a copy of which is filed as an exhibit and incorporated herein by reference.